How COVID-19 is changing rheumatology clinical practice

Full text
Author(s):	Bonfa, Eloisa ; Gossec, Laure ; Isenberg, David A. ; Li, Zhanguo ; Raychaudhuri, Soumya Total Authors: 5
Document type:	Journal article
Source:	Nature Reviews Rheumatology; v. 17, n. 1, p. 5-pg., 2020-11-02.
Abstract
The emergence of COVID-19 in early 2020 led to unprecedented changes to rheumatology clinical practice worldwide, including the closure of research laboratories, the restructuring of hospitals and the rapid transition to virtual care. As governments sought to slow and contain the spread of the disease, rheumatologists were presented with the difficult task of managing risks, to their patients as well as to themselves, while learning and implementing new systems for remote health care. Consequently, the COVID-19 pandemic led to a transformation in health infrastructures and telemedicine that could become powerful tools for rheumatologists, despite having some limitations. In this Viewpoint, five experts from different regions discuss their experiences of the pandemic, including the most challenging aspects of this unexpected transition, the advantages and limitations of virtual visits, and potential opportunities going forward. (AU)

FAPESP's process:	15/03756-4 - Assessment of relevance of blood levels of drugs in the monitoring rheumatic autoimmune diseases: safety, effectiveness and adherence to therapy
Grantee:	Eloisa Silva Dutra de Oliveira Bonfá
Support Opportunities:	Research Projects - Thematic Grants